REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis

T. Yoshino, T. Yamanaka, T. Denda, Y. Tsuji, K. Shinozaki, Y. Komatsu, Y. Kobayashi, J. Furuse, H. Okuda, M. Asayama, K. Akiyoshi, Y. Kagawa, T. Kato, E. Oki, T. Ando, Y. Hagiwara, Y. Ohashi, K. Shitara

研究成果: Contribution to journalArticle査読

本文言語英語
ページ(範囲)v95
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータス出版済み - 6 1 2018

All Science Journal Classification (ASJC) codes

  • 血液学
  • 腫瘍学

引用スタイル